Literature DB >> 19358673

First-line antiretroviral therapy in resource-limited settings: time to reconsider?

Rebecca Adlington, John Richens, Maryam Shahmanesh.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19358673     DOI: 10.1086/597809

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.

Authors:  Moussa Thiam; Halimatou Diop-Ndiaye; Aminata Diaw Diouf; Nicole Vidal; Ousseynou Ndiaye; Ibrahima Ndiaye; Ndeye Fatou Ngom-Gueye; Sada Diallo; Oumy Diop Diongue; Makhtar Camara; Abdoulaye Seck; Souleymane Mboup; Coumba Toure-Kane
Journal:  J Clin Microbiol       Date:  2012-12-12       Impact factor: 5.948

2.  First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.

Authors:  Andrea L Ciaranello; Shahin Lockman; Kenneth A Freedberg; Michael Hughes; Jennifer Chu; Judith Currier; Robin Wood; Charles B Holmes; Sandy Pillay; Francesca Conradie; James McIntyre; Elena Losina; Rochelle P Walensky
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

3.  Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?

Authors:  Francesco Castelli; Virginio Pietra; Ismael Diallo; Richard F Schumacher; Jacques Simpore
Journal:  Open AIDS J       Date:  2010-01-19

4.  Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review.

Authors:  Joshua B Mendelsohn; Marian Schilperoord; Paul Spiegel; David A Ross
Journal:  Confl Health       Date:  2012-10-31       Impact factor: 2.723

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.